WASHINGTON (AP): The Food and Drug Administration says it has approved the first generic versions of the blockbuster antidepressant drug Cymbalta, offering lower-cost access to one of the most widely prescribed anti-anxiety drugs. Cymbalta is Indiana-based Eli Lilly and Company's best-selling medication.